{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:19:49Z","timestamp":1760347189930,"version":"3.37.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Primary cutaneous amoebiasis is rare, and typically affects immunocompromised patients and presents with unique clinical and histopathologic changes. Untreated, the infection could progress to involve the central nervous system, which is almost universally fatal. We present a case of primary cutaneous acanthamoebiasis in a patient with chronic lymphocytic leukemia on acalabrutinib. Timely diagnosis and treatment resulted in complete resolution of lesions and a disease-free status at the 14-month follow-up. A 76-year-old man presented with a 2-month history of multiple, nonhealing, ulcerated, erythematous, painful, crusted nodules on his trunk, and upper and lower extremities. Two punch biopsies showed mixed inflammatory infiltrate with a histiocytic reaction and microabscesses extending into the deep dermis. Rare, unusual structures with cytoplasmic vacuolations and round nuclei were seen on repeated biopsies. Gomori methenamine silver delineated wrinkled double-walled cytoplasm of rare parasites, concerning for amoebic infection. Molecular workup (polymerase chain reaction) came back positive for <jats:italic toggle=\"yes\">Acanthamoeba castellanii<\/jats:italic>. Initial treatment involved flucytosine and fluconazole, followed by fluconazole and miltefosine, but both were discontinued because of nausea and replaced with single-agent voriconazole. Acanthamoeba cutis poses unique diagnostic challenges in a setting of novel agents for chronic lymphocytic leukemia and may be underrecognized. With the expanding population of immunocompromised patients, rare cutaneous infections should enter the differential early on along with early consideration of molecular ancillary testing. The long-term immunomodulating properties of acalabrutinib remain to be elucidated.<\/jats:p>","DOI":"10.1097\/dad.0000000000002903","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T13:01:29Z","timestamp":1735650089000},"page":"224-232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Successful Treatment of Primary Acanthamoeba Cutis in a Patient With Chronic Lymphocytic Leukemia on Acalabrutinib"],"prefix":"10.1097","volume":"47","author":[{"given":"Anna Sarah","family":"Erem","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine Chu","family":"McAllister","sequence":"additional","affiliation":[{"name":"Dermatology Associates of Ithaca, Ithaca, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Quattrochi","sequence":"additional","affiliation":[{"name":"Inform Diagnostics, Coppell, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Vagelos College of Physician and Surgeons of Columbia University and New York Presbyterian Hospital, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"R2-20250214","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdcr.2022.08.008","article-title":"Isolated cutaneous acanthamoebiasis under prophylactic anticryptococcal treatment in an immunocompromised patient","volume":"28","author":"Stetkevich","year":"2022","journal-title":"JAAD Case Rep"},{"key":"R3-20250214","first-page":"6514604","article-title":"Amebic encephalitis in a patient with chronic lymphocytic leukemia on ibrutinib therapy","volume":"2018","author":"Voshtina","year":"2018","journal-title":"Case Rep Hematol"},{"key":"R4-20250214","doi-asserted-by":"crossref","first-page":"ofaa025","DOI":"10.1093\/ofid\/ofaa025","article-title":"Fulminant acanthamoeba castellanii encephalitis in an ibrutinib-treated patient","volume":"7","author":"Crothers","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R5-20250214","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/modpathol.3800973","article-title":"Histopathologic spectrum and immunohistochemical diagnosis of amebic meningoencephalitis","volume":"20","author":"Guarner","year":"2007","journal-title":"Mod Pathol"},{"key":"R6-20250214","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpddr.2019.10.003","article-title":"Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia","volume":"11","author":"Kangussu-Marcolino","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"R7-20250214","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ajcp\/aqv081","article-title":"Disseminated acanthamoeba infection presenting with cutaneous lesions in an immunocompromised patient: a case report, review of histomorphologic findings, and potential diagnostic pitfalls","volume":"145","author":"Morrison","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R8-20250214","doi-asserted-by":"crossref","first-page":"720704","DOI":"10.3389\/fonc.2021.720704","article-title":"Monitoring and managing BTK inhibitor treatment-related adverse events in clinical practice","volume":"11","author":"O'Brien","year":"2021","journal-title":"Front Oncol"},{"key":"R9-20250214","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1097\/01.HS9.0000850356.49024.36","article-title":"PB1876: acalabrutinib related infectious complications-a systematic review and meta-analysis of phase III RCT","volume":"6","author":"Parmar","year":"2022","journal-title":"Hemasphere"},{"key":"R10-20250214","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1001\/jama.285.19.2450","article-title":"Amoebic encephalitis due to Sappinia diploidea","volume":"285","author":"Gelman","year":"2001","journal-title":"JAMA"},{"key":"R11-20250214","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jac\/dkab397","article-title":"Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib","volume":"77","author":"Teh","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"R12-20250214","first-page":"749","article-title":"Acquired immunodeficiency syndrome associated with Acanthamoeba infection and other opportunistic organisms","volume":"110","author":"Gonzalez","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20250214","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0190-9622(00)90110-5","article-title":"Cutaneous acanthamoebiasis in AIDS","volume":"42","author":"Torno","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R14-20250214","doi-asserted-by":"crossref","first-page":"e12661","DOI":"10.1111\/tid.12661","article-title":"Disseminated A infection in a heart transplant recipient treated successfully with a miltefosine\u2010containing regimen: case report and review of the literature","volume":"19","author":"Brondfield","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R15-20250214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4303\/jnp\/N120801","article-title":"Cutaneous acanthamoebiasis with CNS involvement post-transplantation: implication for differential diagnosis of skin lesions in immunocompromised patients","volume":"3","author":"D'Auria","year":"2012","journal-title":"J Neuroparasitol"},{"key":"R16-20250214","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/DAD.0000000000000060","article-title":"Transplant patient with skin nodules","volume":"37","author":"Kandukuri","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R17-20250214","doi-asserted-by":"crossref","first-page":"e12843","DOI":"10.1111\/tid.12843","article-title":"Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient","volume":"20","author":"Kutner","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"R18-20250214","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-3062.2006.00159.x","article-title":"A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient","volume":"9","author":"Walia","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"R19-20250214","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/2229-5070.149888","article-title":"Balamuthia mandrillaris: morphology, biology, and virulence","volume":"5","author":"Siddiqui","year":"2015","journal-title":"Trop Parasitol"},{"key":"R21-20250214","doi-asserted-by":"crossref","first-page":"1377302","DOI":"10.3389\/fmed.2024.1377302","article-title":"Disseminated Acanthamoeba castellanii infection in a patient with AIDS: a case report and literature review","volume":"11","author":"Jiang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R20-20250214","doi-asserted-by":"crossref","first-page":"e0008425","DOI":"10.1371\/journal.pntd.0008425","article-title":"Antineoplastic kinase inhibitors: a new class of potent anti-amoebic compounds","volume":"15","author":"Sauvey","year":"2021","journal-title":"Plos Negl Trop Dis"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T14:00:55Z","timestamp":1739541655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002903","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"type":"print","value":"0193-1091"},{"type":"electronic","value":"1533-0311"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}